紫元元(08223.HK)擬3100萬元購買廣州盛成敦南企業全部股權
格隆匯11月27日丨紫元元(08223.HK)公佈,於2020年11月27日,賣方與買方深圳市美佳爾健康管理有限公司(公司間接全資附屬公司)訂立股權轉讓協議,買方已有條件同意購買目標公司廣州盛成敦南企業管理有限公司全部股權,代價為人民幣3100萬元。
目標公司主要從事投資控股,其旗下多家附屬公司主要於廣州市提供月子服務。
集團相信,2019冠狀病毒病疫情過後,由於人們優先考慮身心健康,並趨向更健康的生活方式,大健康產業將成為極具增值潛力的新經濟突破點。集團搶先佈局醫療器械租賃和相關領域,搶佔風口先機,幫助醫療及相關行業的產業升級。集團認為收購事項為將其業務擴展至月子服務產業的絕佳機會,符合集團的業務前景,並符合公司及股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.